bioRxivImmunology
Aberrant localization of CDC42 C-terminal variants to the Golgi apparatus drives pyrin inflammasome-dependent autoinflammation
M. Nishitani-Isa, K. Mukai, Y. Honda, H. Nihira, H. Shibata, T. Tanaka, K. Kodama, E. Hiejima, K. Izawa, Y. Kawasaki, M. Osawa, Y. Katata, S. Onodera, T. Watanabe, S. Kure, J. Takita, O. Ohara, M. K. Saito, R. Nishikomori, T. Taguchi, Y. Sasahara, T. Yasumi
Abstract
Mutations in the C-terminal region of the CDC42 gene cause severe neonatal-onset autoinflammation. Elevated levels of serum IL-18 in patients and effectiveness of IL-1{beta}-blocking therapy indicate that the pathology involves abnormal inflammasome activation; however, the mechanism underlying autoinflammation remains to be elucidated. Using induced-pluripotent stem cells established from patients carrying CDC42R186C, we found that patient-derived cells secreted larger amounts of IL-1{beta} in response to pyrin-activating stimuli. Aberrant palmitoylation and localization of CDC42R186C protein to the Golgi apparatus promoted pyrin inflammasome assembly downstream of pyrin dephosphorylation. Aberrant subcellular localization was the common pathological feature shared by CDC42 C-terminal variants with inflammatory phenotypes, including CDC42*192C*24 that also localizes to the Golgi apparatus. Furthermore, the level of pyrin inflammasome overactivation paralleled that of mutant protein accumulation in the Golgi apparatus, but no that of the mutant GTPase activity. These results reveal an unexpected association between CDC42 subcellular localization and pyrin inflammasome activation that could pave way for elucidating the mechanism of pyrin inflammasome formation.
- organism: human
- assay: proteomics
- research focus: host-pathogen & immune response
- research focus: cell signaling & trafficking
- research focus: cell type annotation
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A toxic palmitoylation on Cdc42 drives a severe autoinflammatory syndrome
Bahia Bekhouche, Aurore Tourville, … Jérôme Delon·bioRxiv·Oct 17, 2019
- Autoinflammatory patients with Golgi-trapped CDC42 exhibit intracellular trafficking defects leading to STING hyperactivation
A. Iannuzzo, S. Delafontaine, … J. Delon·bioRxiv·Jan 31, 2024
- C-terminal CDC42 variants in autoinflammatory patients specifically trigger actin defects and NF-kB hyperactivation
Alberto Iannuzzo, Philippe Mertz, … Jérôme Delon·bioRxiv·Jun 26, 2024
- Caspase-4 dimerisation and D289 auto-processing elicits an interleukin-1β converting enzyme
A. H. Chan, K. Vezyrgiannis, … K. Schroder·bioRxiv·Jan 5, 2023
- CARD8 negatively regulates NLRP1 inflammasome activation level by interaction with NLRP1
- NLRP3 Cys126 palmitoylation by ZDHHC7 Promotes Inflammasome Activation